arrow
A

Amparo García-Tejedor

University of Barcelona
H指数:18
被引数:812

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ultrasound-guided ethanol sclerotherapy versus laparoscopic surgery for endometriomas: a randomized clinical trial in a real-world setting
2025-11-010
OAAI
Effectiveness and safety of an absorbable modified polymer starch powder hemostat versus usual care in gynecology procedures: A prospective, multi-center, and randomized study

可吸收改性聚合物淀粉粉末止血剂在妇科手术中的有效性与安全性研究:一项前瞻性、多中心、随机研究

2025-09-110
OAAI
Prognostic Outcomes by Axillary Approach in Lobular and Ductal Breast Cancer with Sentinel Node Macrometastases: A Retrospective Cohort Study.

腋窝处理方式对伴有前哨淋巴结大肿块转移的腺管癌和导管癌患者的预后结局影响:一项回顾性队列研究。

2025-08-050
PRE
Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial

D-BIOMARK临床试验的窗口期研究结果:Denosumab作为免疫调节剂在HER2阴性早期乳腺癌中的应用

2025-05-120
OA
Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival-a propensity score cohort study

cN0乳腺癌患者新辅助化疗前后的前哨淋巴结活检: 对腋窝发病率和生存率的影响-倾向评分队列研究

2024-04-181
OAAI
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
2023-08-0913
OAAI
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact
2023-04-120
OA
First results of the randomized window of opportunity clinical trial D-Biomark: Immunomodulatory effect of denosumab in early breast cancer
2022-02-150
PRE
Morphologic characterization of tumor-infiltrating lymphocytes and its relation with pathological response in a series of breast cancer patients treated with primary chemotherapy
2022-02-150
PRE
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials
2021-06-0412
PREAI
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
2020-10-1714
PREAI
Ethanol Sclerotherapy versus Laparoscopic Surgery for Endometrioma Treatment: A Prospective, Multicenter, Cohort Pilot Study
2020-07-0128
OAAI
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution (vol 9, 707, 2019)
2019-09-251
OAAI